TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06709742

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gross Motor Function Measure-88 Based Therapy
Description: Children will be assessed initially by using GMFM-88 and selecting specific items for individuals according to his/her needs with the help of experts and family. At least 3 items will be selected for each subject in which they score less such that 0, 1 or 2. Training based on those specific items will be given to the children. This is goal-oriented training in which, according to the needs of children training will be provided.
Study: NCT05420467

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epirubicin
Description: 90 mg/m2, d1, q3w ,4 cycles ,followed by docetaxel
Study: NCT06707285

Intervention type: DEVICE
Intervention: MRI
Description: 1.5T siemens
Study: NCT06708585

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: progressive relaxation exercises and training
Description: Considering the high incidence of cesarean section and the prevalence of anxiety and fear as psychological symptoms, providing comfort and pain support to women is of great importance. Therefore, the effect of progressive relaxation exercise and education before cesarean section surgery on care outcomes will be determined.
Study: NCT06710171

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Counseling
Description: The intervention consists of using a theory-informed approach to user-centered brief counselling about PrEP uptake, designed specifically to help busy front-line providers in public health, sexual health and primary care settings advance clients along the PrEP cascade (specifically, supporting clients who meet evidence-based criteria for PrEP in accepting provider recommendations to use it) and provide linkage to care for related conditions.~The intervention will be delivered to GBM through participating healthcare providers who would have completed an online training designed by the research team.

Intervention type: OTHER
Group type: OTHER
Intervention: List of resources
Description: This list includes webpages which contain generic information about GBMs sexual health, PrEP, mental health, information about province-wide info lines for the general public about sexual health and/or educational resources for providers.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: List of resources
Description: This list includes webpages which contain generic information about GBMs sexual health, PrEP, mental health, information about province-wide info lines for the general public about sexual health and/or educational resources for providers.
Study: NCT06708078

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Follow-up according to the Canhope allied health support program
Description: The Canhope allied health support program consists in:~* providing information tailored to patients' needs, with a dedicated time for patients to ask questions, obtain answers tailored to their needs, and be aware of the resources available to them;~* organizing peer-patient focus groups.~And aims at:~* reducing anxiety and improving patients' quality of life;~* better taking into account the impact of the announcement of intracranial Aneurysm, and to provide them with specific support.~* managing the emotional consequences of the announcement and the uncertainty of living with an intracranial Aneurysm.
Study: NCT06709638

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Placebo Comparator

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zhilong Huoxue Tongyu capsule
Description: Zhilong Huoxue Tongyu capsule
Study: NCT06709105

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotape
Description: The application was performed using 5 cm x 5 m kinesio tape material. After preparing the standing patient in terms of clothing and skin readiness, the patient was asked to lean forward. To adhere the tape to the right paravertebral region, the lower end of the tape was first adhered 7 cm below the sacroiliac joint at the level of the paravertebral muscles. Then, while the patient was leaning forward, a slight rotation to the left was requested, and in this position, the tape was adhered upwards along the paravertebral muscles without any tension. When applying the tape to the left paravertebral region, the same procedure was mirrored as on the right, with the tape again applied without any tension. The third tape was applied while the patient was standing upright and leaning slightly forward, placed over the sacroiliac joints and parallel to the floor, stretching the tape by 25%.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham (no implant)
Description: Sham Kinesio taping was applied to the patients in the control group. In this sham protocol, Kinesio bands were attached between the 12th rib on both sides and the corresponding sacroiliac joint, passing over the paravertebral muscles without employing any specific banding technique. The third tape was adhered between both sacroiliac joints, also without any adhesive technique. Patients were inquired about any discomfort and informed that the tapes would remain in place until the second session.
Study: NCT06707753

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AL-001
Description: Administered via suprachoroidal space injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AL-001
Description: Administered via suprachoroidal space injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AL-001
Description: Administered via suprachoroidal space injection.
Study: NCT06709859

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afatinib plus chemotherapy as conversion treatment
Description: Patients with unresectable EGFR sensitive mutation-positive stage III NSCLC will receive 3-4 cycles of afatinib plus chemotherapy as the conversion treatment, and then surgery will be provided for patients who are suitable for primary tumor resection.
Study: NCT06684327

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-paclitaxel Injection
Description: Participant will receive albumin-paclitaxel 260mg/m2 d1, isocyclophosphamide 1500mg/m2 d2-5, and cisplatin 25mg/m2 d2-5 every 21 days until disease progression, intolerable toxicity, or full 6 cycles of treatment, whichever occurs first.
Study: NCT06710236

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hearing instrument
Description: Conventional, daily wear hearing instruments will be used in this study.
Study: NCT06709716

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quadratus Lumborum Block (QLB)
Description: Pre-operative quadratus lumborum block with liposomal bupivacaine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Quadratus lumborum block
Description: Pre-operative quadratus lumborum block with saline

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Local Anesthetic Solution
Description: Intraoperative injection of 0.25% bupivacaine at each incision site

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Local Anesthetic Solution
Description: Intraoperative injection of saline at each incision site.
Study: NCT06708351

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive standard care

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Promotion and Education
Description: Receive instructions on how to use HPV self-testing kit

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: HPV Self-Collection
Description: Undergo HPV self-collection

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Text Message-Based Navigation Intervention
Description: Receive text messages for HPV testing results and triage and treatment reminders
Study: NCT05653024

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salbutamol
Description: 8 puffs of 100 mcg inhaled salbutamol administered with spacer

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 8 puffs of placebo inhaler administered with spacer
Study: NCT06709365

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tibiotalar calcaneal fusion by hindfoot
Description: Hindfoot nail for ankle fusion

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tibiotalar calcaneal fusion by hindfoot
Description: Hindfoot nail for ankle fusion
Study: NCT06737562

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immediatly sequential bilateral cataract surgery
Description: Immediatly sequential bilateral cataract surgery
Study: NCT05308459

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Data-driven health promotion at Vocational Education and Training schools (Data Health VET)
Description: The intervention consists of the following steps:~1. A local health profile is conducted among all students~2. Results are shortly hereafter presented and discussed with all student and staff, and the school decide what health problem they will work with during the next year~3. A participatory group model process based on a dynamic systems approach is conducted to develop sustainable and system changing activities to address the chosen health problem~4. The activities are implemented~5. A new health profile is conducted to a) evaluate the effects of the implemented activities and to b) determine if a new health problem warrant focus and new activities are needed (the process repeats itself).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Data-driven health promotion at Vocational Education and Training schools (Data Health VET)
Description: The intervention consists of the following steps:~1. A local health profile is conducted among all students~2. Results are shortly hereafter presented and discussed with all student and staff, and the school decide what health problem they will work with during the next year~3. A participatory group model process based on a dynamic systems approach is conducted to develop sustainable and system changing activities to address the chosen health problem~4. The activities are implemented~5. A new health profile is conducted to a) evaluate the effects of the implemented activities and to b) determine if a new health problem warrant focus and new activities are needed (the process repeats itself).
Study: NCT06737562

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Delayed sequential bilateral cataract surgery
Description: Delayed sequential bilateral cataract surgery : 3 weeks +/-1 week between the two procedures
Study: NCT06737653

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gel containing postbiotics, lactoferrin, aloe barbadensis leaf juice powder and sodium hyaluronate
Description: The gel will be applied until the wound is filled with the gel, which will be left undisturbed for 5 min.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo gel
Description: The gel will be applied until the wound is filled with the gel, which will be left undisturbed for 5 min.
Study: NCT06731504

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abatacept
Description: Abatacept is a monoclonal antibody that suppresses T-cell activation through costimulatory blockade. In 2021, abatacept was FDA approved to prevent acute GVHD following allogeneic HCT.
Study: NCT06745375

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: contact lens wear
Description: participants wear two different powered contact lenses (one with actual power, and one +/- 2.00Ds) contact lenses. No 2nd arm
Study: NCT06744842

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: genicular nerve block
Description: genicular nerve block

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: isometric exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: isometric exercise
Study: NCT06745453

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block
Description: Erector Spinae Plane Block

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham Procedure
Description: Sham Procedure
Study: NCT06736327

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKB500
Description: The administration route of SKB500 is intravenous infusion, with a dosing frequency of Q3W.
Study: NCT06744738

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharmacist led behavioral change technique
Description: The intervention was developed based on the behavior change technique taxonomy (v1). This intervention was designed to improve adherence to all therapeutic aspects of hemodialysis patients, including the dialysis program, medications, diet, and fluids. Additionally, the effect of the pharmacist intervention on physiological indices (serum potassium, total calcium, phosphate, IDWG, and hemoglobin) was examined.~The program was explicitly created for implementation in an actual setting, ensuring that the time allocation for participants and facilitators (the party responsible for conducting the PL-BCT) remained reasonable in most contexts.~The BCT components were developed after the identification and coding of the BCTs from previous interventional studies that contain behavioral components and result in positive effects on one or more hemodialysis patients' adherence domains toward their therapeutic regimen (dialysis program, medications, diet, and fluid).
Study: NCT06745388

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Description: Receive intravenous magnesium intra-operatively

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: Receive IV push ketamine intra-operatively

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Receives no additional medication or infusion
Study: NCT06744387

Intervention type: DIAGNOSTIC_TEST
Intervention: clinical assessments and tissue oxygenation monitoring by Near Infrared Spectroscopy
Description: Flap failure will be identified, based upon gold standard monitoring (flaps skin color, temperature, tissue turgor and capillary refill time) along with Doppler technique during a postoperative period of seven days. In all patients Near Infrared Spectroscopy (NIRS) by FORE-SIGHT ELITE will be applied to obtain continuous tissue oxygenation measurements. NIRS values and trends from patients with flap failure (case group) will be compared to NIRS values and trends from patients with no flap failure(control group).
Study: NCT06744465

Intervention type: DEVICE
Intervention: NearWave monitoring
Description: NearWave optical molecular monitoring
Study: NCT06745635

Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: Usual care for immunizations.

Intervention type: OTHER
Group type: OTHER
Intervention: Multifaceted intervention
Description: The multifaceted quality improvement intervention includes: video-based training on vaccine management in SUS, an optimized Cold Chain Manual schema, technical documents on proper vaccine handling and immunization schedules, and checklists for managing post-vaccination errors and corrective procedures. Videos will focus on six key points (right person, vaccine, dose, time, route, and documentation), with each lasting about 2 minutes and accessible on-demand. The Cold Chain schema will cover storage, monitoring, transport, conservation, and handling, with checklists for each category. Standardized technical documents will align with video themes, ensuring protocol adherence. An error identification and management schema will address issues like improper vaccine administration, cold chain violations, and incorrect dosages. This schema will be reviewed by staff and made available in health units.
Study: NCT06744634

Intervention type: OTHER
Intervention: Romania group
Description: The questionnaire which was prepared by researchers will be performed by older adults from Romania. The sociodemographic characteristics are recorded to part A section of questionnaire. The pain assessment section is part B and evaluate pain localization, intensity, type, factors affecting the pain, coping and management strategies of pain. Health related outcomes will be evaluated with CDC (Center of Disease Control and Prevention) Health related Quality of Life-4 Questionnaire

Intervention type: OTHER
Intervention: Turkey Group
Description: The questionnaire which was prepared by researchers will be performed by older adults from Turkey The sociodemographic characteristics are recorded to part A section of questionnaire. The pain assessment section is part B and evaluate pain localization, intensity, type, factors affecting the pain, coping and management strategies of pain. Health related outcomes will be evaluated with CDC (Center of Disease Control and Prevention) Health related Quality of Life-4 Questionnaire

Intervention type: OTHER
Intervention: Croatia Group
Description: The questionnaire which was prepared by researchers will be performed by older adults from Croatia. The sociodemographic characteristics are recorded to part A section of questionnaire. The pain assessment section is part B and evaluate pain localization, intensity, type, factors affecting the pain, coping and management strategies of pain. Health related outcomes will be evaluated with CDC (Center of Disease Control and Prevention) Health related Quality of Life-4 Questionnaire
Study: NCT06745895

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MATCHES
Description: Participants will be asked to complete a survey with specific topics including Hepatitis C (HCV) and Colorectal (CRC) knowledge and health beliefs, screening intentions and demographic characteristics.~Participants will be provided with education intervention materials (for example, a booklet) either in-person or via mail, access to free stool-based CRC screening, and access to free HCV screening.~Approximately 1-2 weeks after receiving the education materials, participants will be asked to complete a post-intervention survey about the same specific topics (for example, HCV and CRC knowledge, HCV and CRC health beliefs, HCV and CRC screening intentions, healthcare experiences, perceptions of the educational materials) over the phone with a trained study staff.~Participants with a positive HCV screening and/or CRC screening result will be navigated to follow-up care as needed.
Study: NCT06744920

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remibrutinib (Blinded)
Description: Remibrutinib (Blinded) active treatment

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Remibrutinib (Open Label)
Description: Remibrutinib (Open Label) active treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remibrutinib (Open Label)
Description: Remibrutinib (Open Label) active treatment
Study: NCT06743620

Intervention type: OTHER
Intervention: iltamiocel
Description: This is an observational study with no intervention.
Study: NCT06745765

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality headset
Description: Patients will use virtual reality before the procedure in addition to usual preoperative care.
Study: NCT06744946

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: thoracoscope
Description: bleomycin- tranxemic acid mixture pleurodesis versus thoracoscopic talc poudrage
Study: NCT06744348

Intervention type: PROCEDURE
Intervention: ENTİRE PAPİLLA PRESERVATİON
Description: The EPP technique is a tunnel-like approach of the defect-associated inter-dental papilla. Surgical loupes (3.3× magnification) with LED light illumination were used to increase visibility of the surgical site. Following a buccal intra-crevicular incision, a bevelled vertical releasing incision was performed in the buccal gingiva of the neighbouring inter-dental space and extended just beyond the mucogingival line to provide appropriate mechanical access to the intrabony defect.
Study: NCT06745648

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Combination of right carotid sinus massage and modified Trendelenburg position
Description: The modified Trendelenburg position is combined with 3 series of 15 seconds of massage of the right carotid sinus to relieve migraine, tension and mixed headaches, monitoring blood pressure, heart rate and oxygen saturation.
Study: NCT06745622

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK39297 tablets
Description: HSK39297 tablets until the end of treatment
Study: NCT06744478

Intervention type: DEVICE
Intervention: Misight 1 Day Contact Lens
Description: Misight 1 Day Contact Lens wearing for myopia control
Study: NCT06745544

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rhythm- and Multitask-Based Activity (RYMA) and Activities of Daily Living (ADL)
Description: The Rhythm- and Multitask-Based Activity (RYMA) program is a unique cognitive-motor exercise intervention designed for older adults with diabetes. It incorporates rhythm-based multitasking exercises, performed to improvised piano music, combined with Activities of Daily Living (ADL)-focused exercises. The intervention targets physical (strength, balance, and coordination) and cognitive (executive function, reaction time) components to reduce fall risk, improve bone health, and optimize cardiovascular outcomes. Delivered over 26 weeks, the program emphasizes social interaction to enhance adherence and long-term engagement.
Study: NCT06734923

Intervention type: OTHER
Intervention: Questionnaire (28 questions)
Description: demographic data, information-seeking behavior, platform use and online consultation habits, trust and impact, and interest in additional resources
Study: NCT06744751

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Fecal Microbiota Transplantation
Description: Patients take the capsules once daily, with a dose of 4 capsules per day, for a total of 12 days (48 capsules in total). Capsule size is selected based on age: patients under 16 use size 3 capsules, while those 16 and older use size 0 capsules. Both the FMT and placebo capsules are identical in appearance, size, color, form, weight, and taste, with the placebo containing starch as the main ingredient.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Manufactured by the same company, the placebo capsules contain starch as the main ingredient and are identical in appearance, size, color, dosage form, weight, and taste to the FMT capsules. They are administered once daily, 4 capsules per dose, for 12 days.
Study: NCT06745193

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chidamide+Camrelizumab+Apatinib
Description: chidamide+Camrelizumab+Apatinib
Study: NCT05402046

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile phone application ProRodinki
Description: Patient were underwent photography using mobile phone and tested application ProRodinkijust before preplanned excisional or incisional biopsy.~Application AI result than will be compared with pathology report by independent investigator
Study: NCT06745193

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Irinotecan or Docetaxel or Paclitaxel
Description: Irinotecan Docetaxel Paclitaxel
Study: NCT06744361

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: esketamine hydrochloride
Description: Prehospital intravenous or intraosseous bolus administration at a minimum of 0.5 mg/kg of esketamine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol
Description: Prehospital intravenous or intraosseous bolus administration at a minimum dose of 0.25 mg/kg propofol